Tianjin Medical Journal ›› 2025, Vol. 53 ›› Issue (12): 1339-1344.doi: 10.11958/20252064

• Review • Previous Articles     Next Articles

Clinical progress of autologous platelet-rich plasma therapy in the treatment of plantar fasciitis

BAI Tianting1(), WANG Xiuping2, FU Yahui3, LIU Lu1, LIU Guoyin1,()   

  1. 1 Department of Orthopaedics, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
    2 Department of Nursing, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
    3 Medical School of Nanjing University
  • Received:2025-05-22 Revised:2025-09-18 Published:2025-12-15 Online:2025-12-08
  • Contact: E-mail:liuguoyin0425@163.com

Abstract:

Plantar fasciitis (PF) is a primary cause of heel pain (HP). Platelet-rich plasma (PRP), as an emerging biological treatment method, possesses unique biological characteristics, showing significant dual therapeutic advantages in suppressing inflammation and promoting tissue repair. This article reviews the pathogenesis of PF, the biological characteristics of PRP and its application in pain management and functional prognosis assessment of PF, particularly focusing on PRP in improving plantar fascia thickness (PFT).

Key words: fasciitis, plantar, platelet-rich plasma, pain management, autologous, plantar fascia thickness

CLC Number: